Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9486926rdf:typepubmed:Citationlld:pubmed
pubmed-article:9486926lifeskim:mentionsumls-concept:C0015498lld:lifeskim
pubmed-article:9486926lifeskim:mentionsumls-concept:C0175816lld:lifeskim
pubmed-article:9486926lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:9486926lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:9486926pubmed:issue1lld:pubmed
pubmed-article:9486926pubmed:dateCreated1998-3-19lld:pubmed
pubmed-article:9486926pubmed:abstractTextAn 81-year-old man known to have a stable cold agglutinin syndrome presented with a progressive cerebral hemorrhage. Coagulation tests revealed prolonged APTT and prothrombin time and severely decreased factor V activity, which could not be normalized by mixing with normal plasma. The patient appeared refractory to substitution with fresh-frozen plasma, suggesting the presence of a circulating inhibitor specific for factor V. To our knowledge, this is the first case of a lymphoproliferative disease leading to a cold agglutinin syndrome and a putative inhibitor of factor V. In patients with paraproteinemia presenting with bleeding diathesis, the presence of a circulating inhibitor of a specific coagulation factor must be considered.lld:pubmed
pubmed-article:9486926pubmed:languageenglld:pubmed
pubmed-article:9486926pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9486926pubmed:citationSubsetIMlld:pubmed
pubmed-article:9486926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9486926pubmed:statusMEDLINElld:pubmed
pubmed-article:9486926pubmed:monthJanlld:pubmed
pubmed-article:9486926pubmed:issn0939-5555lld:pubmed
pubmed-article:9486926pubmed:authorpubmed-author:BreedW PWPlld:pubmed
pubmed-article:9486926pubmed:authorpubmed-author:HoffmannJ JJJlld:pubmed
pubmed-article:9486926pubmed:authorpubmed-author:OostingJ DJDlld:pubmed
pubmed-article:9486926pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:9486926pubmed:issnTypePrintlld:pubmed
pubmed-article:9486926pubmed:volume76lld:pubmed
pubmed-article:9486926pubmed:ownerNLMlld:pubmed
pubmed-article:9486926pubmed:authorsCompleteYlld:pubmed
pubmed-article:9486926pubmed:pagination49-50lld:pubmed
pubmed-article:9486926pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:meshHeadingpubmed-meshheading:9486926-...lld:pubmed
pubmed-article:9486926pubmed:year1998lld:pubmed
pubmed-article:9486926pubmed:articleTitleFactor V inhibitor associated with cold agglutinin disease.lld:pubmed
pubmed-article:9486926pubmed:affiliationDepartment of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.lld:pubmed
pubmed-article:9486926pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9486926pubmed:publicationTypeCase Reportslld:pubmed